Literature DB >> 2198300

Comorbidity of anxiety and depression.

C R Cloninger1.   

Abstract

Many factors obscure the diagnosis of psychogenic disorders, especially anxiety and depression. The factors involved include an overlap of symptoms, discrepancies in diagnostic criteria, and the unreliability of self- and observer-reporting. Differentiation among the various personality disorders is, however, extremely important, both for identifying the most appropriate treatment plan for a given patient and for evaluating the therapeutic activity of newly developed pharmacologic agents. Emerging factors that may have an impact on differential diagnoses of anxiety and depression include age at onset, family history, and personality traits associated with different types of psychopathology.

Entities:  

Mesh:

Year:  1990        PMID: 2198300     DOI: 10.1097/00004714-199006001-00009

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  5 in total

Review 1.  Ten good reasons to consider biological processes in prevention and intervention research.

Authors:  Theodore P Beauchaine; Emily Neuhaus; Sharon L Brenner; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2008

2.  Patterns of psychopathology in the families of children with conduct problems, depression, and both psychiatric conditions.

Authors:  Lisa M Kopp; Theodore P Beauchaine
Journal:  J Abnorm Child Psychol       Date:  2007-01-10

Review 3.  Optimal management of anxiety in older patients.

Authors:  K J Weiss
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

4.  Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression.

Authors:  Nina C Donner; Christian D Montoya; Jodi L Lukkes; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2011-09-15       Impact factor: 4.905

5.  Enhanced Risk Aversion, But Not Loss Aversion, in Unmedicated Pathological Anxiety.

Authors:  Caroline J Charpentier; Jessica Aylward; Jonathan P Roiser; Oliver J Robinson
Journal:  Biol Psychiatry       Date:  2016-12-16       Impact factor: 13.382

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.